Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01379053 · ClinicalTrials.gov registry record

Volatile Organic Compounds in Staphylococcus Aureus Patients

A clinical trial, sponsored by Landon Pediatric Foundation.

Completed
Registry status
10
Enrollment target

NCT01379053 is a clinical trial that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01379053 has completed, sponsored by Landon Pediatric Foundation.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

The zNose® MRSA test is a non-invasive breath test for markers of Staphylococcus aureus, which may predict the probability of bacterial organisms in the anterior nares, throat and respiratory tract, wounds, and anus and therefore be able to replace or supplement current active Methicillin Resistant Staphylococcus Aureus (MRSA) surveillance efforts. It consists of: * A collection apparatus for collection of volatile compounds from suspected infection sites onto a sorbent trap or Tedlar bag, as well as for the collection of a separate sample of room air. * Analysis of the volatile organic compounds from suspected infection sites and room air by short acoustic wave gas chromatography. * Interpretation of the volatile organic compounds with a proprietary algorithm in order to predict the probability of Staphylococcus aureus infection and colonization. This study will test the hypothesis that we can identify the presence of MRSA by sampling the "head space" above culture media of anterior nare samples provided by patients with MRSA. Additionally, this study will test the hypothesis that we can identify the presence of MRSA by sampling air exhaled through the nostrils (nasal exhalant).

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2009-08
Est. Completion 2010-12

Sponsor

Landon Pediatric Foundation

11 total trials

What the Registry Record Tells You About NCT01379053

The ClinicalTrials.gov registry entry for NCT01379053 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Landon Pediatric Foundation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01379053 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01379053 about?

NCT01379053 is a clinical study titled "Volatile Organic Compounds in Staphylococcus Aureus Patients". The zNose® MRSA test is a non-invasive breath test for markers of Staphylococcus aureus, which may predict the probability of bacterial organisms in the anterior nares, throat and respiratory tract, wounds, and anus and therefore be able to replace or supplement current active Methicillin Resistant ...

What is the current status of trial NCT01379053?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2009-08. Estimated completion is 2010-12.

Who is sponsoring clinical trial NCT01379053?

This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.